System Transmission

Top Signal

100#1 JOB

Activity

2188Ripe

+949 today

System

Live2m

Terminal Asset View

stockNASDAQ

RLMD

$5.91-3.90%

Relmada Therapeutics Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

9Overripe

Live Analysis Active

Company Mission

Relmada Therapeutics Inc creates experimental medications for mental health issues, such as depression. Doctors and patients might use these drugs if they prove effective in clinical tests. The company makes money by getting its treatments approved by regulators and then selling them to healthcare systems.

RLM

Industry Context

This company operates in the biotechnology sector, focusing on developing treatments for mental health disorders. It competes with other firms by advancing drugs through clinical trials to gain FDA approval. Success depends on demonstrating safety and efficacy in studies, which can lead to market exclusivity and revenue from prescriptions.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

48Matrix

Market Momentum

61.1— Holding Steady

Trend Strength

75— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.4x— Normal Volume

Today's Change

-3.90%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing RLMD across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 04:16 AM UTC

As-of As of 2026-03-16T04:01:14.287Z UTC (~15m delay).

Develops new antidepressant drugs for patients with major depressive disorder, aiming to generate revenue through FDA approvals and future sales.

No technical indicators available, but watch for price action near key levels as the company progresses through clinical trials, which could signal investor sentiment shifts.

Volume patterns are absent, but monitor if volume spikes on news about trial results or partnerships, indicating potential buying interest from institutional investors.

Industry trends favor mental health innovation, with price holding above support from sector momentum, signaling growth opportunities. Watch for regulatory updates affecting biotech stocks.

Educational only.

Precision Intelligence Model

Live Terminal Stream

Loading chart...